SEC Form 4 · accession 0000919574-18-005360
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Broadfin Healthcare Master Fund Ltd
10% Owner
Broadfin Capital, LLC
10% Owner
Kevin Kotler
10% Owner
Period of report
Aug 9, 2018
Accepted (ET)
Aug 13, 2018 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F1,F2 | $3.33 | Aug 9, 2018 | G | 10,000 | D | — | Aug 9, 2028 | Common Shares | 10,000 | 19,600 | D |
| Stock Option (Right to Buy)F4,F1,F2 | $3.33 | Aug 9, 2018 | G | 10,000 | A | — | Aug 9, 2028 | Common Shares | 10,000 | 19,600 | D |
Explanation of responses
- F1Each stock option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- F2The option shall vest in twelve equal monthly installments, beginning one month after the grant date.
- F3The stock options were granted to Kevin Kotler for service as a member of the Issuer's Board of Directors.
- F4The securities are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.